Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2006 / Cilt: 16 - Sayı: 2

The frequencies of factor V leiden and prothrombin 20210A gene mutations in healthy children

Sağlıklı çocuklarda faktör V leiden ve protrombin 20210 A mutasyon sıklıkları

Pages
77–81
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our findings suggest that while the frequency of FVL mutation in our trial is similar to the results of the other studies reported in our country, the frequency of prothrombin 20210A mutation is higher than those of reported from Ankara and Edirne.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to evaluate the frequencies of Factor V Leiden (FVL) and prothrombin 20210A mutations in healthy children.
📊
Key Findings & Data:In this study, 496 healthy children were enrolled.
💡
Conclusion & Impact:Our findings suggest that while the frequency of FVL mutation in our trial is similar to the results of the other studies reported in our country, the frequency of prothrombin 20210A mutation is higher than those of reported from Ankara and Edirne.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Protrombin · Çocuk · Nokta mutasyonu

Abstract

The aim of this study was to evaluate the frequencies of Factor V Leiden (FVL) and prothrombin 20210A mutations in healthy children. In this study, 496 healthy children were enrolled. We studied FVL and prothrombin 20210A mutations with real-time polimerase chain reaction. Median age was 5 years (10mos -16 yrs). The frequency of FVL mutation was 7.1%. While thirty four of 35 cases had heterozygous, one patient had homozygous FVL mutation. Similarly, the frequency of prothrombin 20210A mutation was 6.9%. Thirty three of 34 cases had heterozygous, one patient had homozygous prothrombin 20210A mutation. One patient had both FVL and protrombin 20210A heterozygous mutations. The presence of FVL and protrombin 20210A mutations were statistically independent from gender and family history of thrombosis. To the best of our knowledge, this is the first study, investigating the frequencies of FVL and protrombin 20210A mutations in childhood in Çukurova region. Our findings suggest that while the frequency of FVL mutation in our trial is similar to the results of the other studies reported in our country, the frequency of prothrombin 20210A mutation is higher than those of reported from Ankara and Edirne.

Özet

Sağlıklı çocuklarda venöz tromboza eğilim yaratan kalıtsal faktörlerden en sık görülen ve bölgesel farklılıklar gösterebilen Faktör-V Leiden (FVL) ve protrombin 20210A mutasyon sıklıklarının araştırılması amaçlandı. Bu çalışmada 258 erkek, 238 kız toplam 496 sağlıklı çocuk çalışmaya alındı. PCR yöntemiyle FV 1691A ve protrombin 20210A mutasyonları araştırıldı. Ortanca yaş 5 yıl (10 ay-16 yıl) bulundu. Otuzdört vakada heterozigot, bir vakada homozigot olmak üzere toplam 35 vakada (%7.1) FVL mutasyonu saptandı. Otuzüçü heterozigot, bir vaka homozigot olmak üzere toplam 34 vakada (% 6.9) protrombin 20210A mutasyonu gösterildi. Bir vakada hem heterozigot FVL hem de heterozigot protrombin 20210A mutasyonu birlikteliği saptandı. FVL mutasyonu ve protrombin 20210A mutasyonu varlığı cinsiyet ve ailede tromboz öyküsü varlığından bağımsız bulundu. Bilgilerimize göre çocukluk çağında FVL ve protrombin 20210A mutasyon sıklığı konusunda Çukurova Bölgesi’nde yapılan ilk çalışmadır. Bulgularımız FVL mutasyon sıklığının ülkemizdeki diğer bölgelerle benzer olduğunu, protrombin 20210A mutasyon sıklığının Ankara ve Edirne’deki çalışmalara göre daha yüksek olduğunu düşündürmüştür.

🔖

Cite This Article

ERTÜRK, C., DÜZOVALI, Ö., MUŞLU, N., ESKANDARİ, G., KANIK, A., YILGÖR, E. (2006). The frequencies of factor V leiden and prothrombin 20210A gene mutations in healthy children. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 16 - Sayı: 2, 77–81. https://ajindex.com/articles/323090

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Federman G.D, Kirsner S.R. An update on hypercoagulable disorders. Arch Intern Med 161: 1051-1056, 2001
  2. De Stefano V, Finazzi G, Mannucci M.P. Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 87(9): 3531- 3544, 1996
  3. Dahlback B, Carlsson M, Svensson PJ. Familial Thrombophilia due to a previously unrecognized mechanism characterized by poor anticoogulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008, 1993
  4. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67, 1994
  5. Gürgey A, Mesci L. The Prevalence of Factor V Leiden (1691G A) Mutation Turkey. Turk J Pediatr 39: 313-315, 1997
  6. Akar N, Akar E, Dalgin G, et al. Frequency of factor V (1691G ---'> A) mutation in Turkish population. Thromb Haemost 78: 1527- 1529,1997
  7. Özbek U, and Tangün Y. Frequency of factor V Leiden (Arg506GIn) in Turkey. Int J Haematol 64: 291- 292, 1996
  8. Akar N, Akar E, Yılmaz E, Sözüöz A. Frequency of FV 1299 His-Arg (A4070G) in Turkish Cypriots. Turk J Haematol 18: 243-244, 2001
  9. Vurkun M, Vural F, Demir M, et al. The prevalence of activated protein C resistance and FV Leiden in healty population of Edirne, Turkey. Turk J Haematol 19 (2):287-291, 2002
  10. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 346: 1133-1134, 1995
  11. Ferrer-Antunes C, Palmeiro A, Green F, et al. Polymorphisms of fibrinogen, factor VII and factor V genes: Comparison of allele frequencies in different ethnic groups. [Abstract]. Thromb Haemost 73:1379, 1995
  12. Lucotte G and Mereier G. Frequency of Factor V Leiden (Arg506Gln) in France. Br J Haematol 99: 237-241, 1997
  13. Akar N, Mısıroğlu M, Akar E, et al. Prothrombin gene 20210 G A mutation in the Turkish Population. Am J Hematol 58: 249, 1998
  14. Rosendaal FR, Doggen CJM, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79: 706- 708, 1998
  15. Franco F.R, Trip M.D, Cate H.T, et al. The 20210 G_A mutation in the 3-untranslated region of the prothrombin gene and the risk arterial thrombotic disease. Br J Haematol 104: 50- 54, 1999
  16. Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost 6: 104- 107, 2000
  17. Tamim H, Fınan R.R, Almawi W.Y. Pre